Are you a Patient?
Canxiol is committed to the ongoing safety surveillance of our prescription medicines. If you or someone in your care has experienced a suspected adverse reaction, please choose the pathway below to access the appropriate reporting documents and procedures.
Patients
Report an adverse effect
If you are taking Canxiol and experiencing unexpected symptoms or side effects, you can report them directly using the official consumer reporting forms provided through the Pharmacovigilance Programme of India.
Reporting a adverse effect
Healthcare professionals and patients are encouraged to report any suspected adverse reactions.
Leiutis Medical & Pharmacovigilance Center
Please write to us for any adverse effects
- Email:
- write@leiutis.com
- Direct Phone:
- +91 40 23077365
India’s Pharmacovigilance Programme (PvPI)
Adverse events can also be reported to the national pharmacovigilance centre under the Indian Pharmacopoeia Commission (IPC):
- National Toll-Free:
- 1800-180-3024
- Portal:
- www.ipc.gov.in (PvPI Portal)
